The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Nanoparticles in Medicine: Therapeutic Applications and Developments
Abstract
Nanotechnology is the understanding and control of matter generally in the 1-100 nm dimension range. The application of nanotechnology to medicine, known as nanomedicine, concerns the use of precisely engineered materials at this length scale to develop novel therapeutic and diagnostic modalities. Nanomaterials have unique physicochemical properties, such as ultra small size, large surface area to mass ratio, and high reactivity, which are different from bulk materials of the same composition. These properties can be used to overcome some of the limitations found in traditional therapeutic and diagnostic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
Hirsch, L. R., Stafford, R. J., Bankson, J. A., Sershen, S. R., Rivera, B., Price, R. E., Hazle, J. D., Halas, N. J., & West, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232479100 · Cited by 3,955
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Micellar Nanocarriers: Pharmaceutical Perspectives
Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Self-citationThe emerging nanomedicine landscape
Wagner, V., Dullaart, A., Bock, A.-K., & Zweck, A. (2006) · Nature Biotechnology · doi:10.1038/nbt1006-1211 · Cited by 1,630
Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474 · cited 1×
“Poly(D,L-lactic acid), poly(D,L-glycolic acid), poly(e-caprolactone), and their copolymers at various molar ratios diblocked or multiblocked with poly(ethylene glycol) are the most commonly used biodegradable polymers to form micelles for drug delivery and controlled release, and have been extensively studied in the p…”
BackgroundMoghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,227
Roy, I., Ohulchanskyy, T. Y., Pudavar, H. E., Bergey, E. J., Oseroff, A. R., Morgan, J., Dougherty, T. J., & Prasad, P. N. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0343095 · Cited by 929
Kukowska-Latallo, J. F., Candido, K. A., Cao, Z., Nigavekar, S. S., Majoros, I. J., Thomas, T. P., Balogh, L. P., Khan, M. K., & Baker, J. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3921 · Cited by 912
Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆
FAROKHZAD, O., & LANGER, R. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.011 · Cited by 800
Self-citationNorthfelt, D. W., Dezube, B. J., Thommes, J. A., Miller, B. J., Fischl, M. A., Friedman-Kien, A., Kaplan, L. D., Du Mond, C., Mamelok, R. D., & Henry, D. H. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2445 · Cited by 649
Liu, Y., Miyoshi, H., & Nakamura, M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22709 · Cited by 620
On the formulation of pH-sensitive liposomes with long circulation times
Simões, S. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.038 · Cited by 483
The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma
Jordan, A., Scholz, R., Maier-Hauff, K., van Landeghem, F. K. H., Waldoefner, N., Teichgraeber, U., Pinkernelle, J., Bruhn, H., Neumann, F., Thiesen, B., et al. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-9059-z · Cited by 459
Inflammation in Atherosclerosis: Visualizing Matrix Metalloproteinase Action in Macrophages In Vivo
Deguchi, J.-O., Aikawa, M., Tung, C.-H., Aikawa, E., Kim, D.-E., Ntziachristos, V., Weissleder, R., & Libby, P. (2006) · Circulation · doi:10.1161/circulationaha.106.619056 · Cited by 419
Targeted Nanoparticles for Cancer Therapy
Reddy, G. S. N. (2021) · Journal of Bioanalysis & Biomedicine · Cited by 401
Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer
Kawasaki, E. S., & Player, A. (2005) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.03.002 · Cited by 368
McCarthy, T. D., Karellas, P., Henderson, S. A., Giannis, M., O'Keefe, D. F., Heery, G., Paull, J. R. A., Matthews, B. R., & Holan, G. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050023q · Cited by 314
Morgan, M. T., Nakanishi, Y., Kroll, D. J., Griset, A. P., Carnahan, M. A., Wathier, M., Oberlies, N. H., Manikumar, G., Wani, M. C., & Grinstaff, M. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2066 · Cited by 301
Hyung Park, J., Kwon, S., Lee, M., Chung, H., Kim, J.-H., Kim, Y.-S., Park, R.-W., Kim, I.-S., Bong Seo, S., Kwon, I. C., et al. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.05.028 · Cited by 296
A New Class of Silica Cross-Linked Micellar Core−Shell Nanoparticles
Huo, Q., Liu, J., Wang, L.-Q., Jiang, Y., Lambert, T. N., & Fang, E. (2006) · Journal of the American Chemical Society · doi:10.1021/ja060367p · Cited by 295
Drug loaded magnetic nanoparticles for cancer therapy
Jurgons, R., Seliger, C., Hilpert, A., Trahms, L., Odenbach, S., & Alexiou, C. (2006) · Journal of Physics: Condensed Matter · doi:10.1088/0953-8984/18/38/s24 · Cited by 281
Davis, F. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00021-2 · Cited by 278
How to Stabilize Phospholipid Liposomes (Using Nanoparticles)
Zhang, L., & Granick, S. (2006) · Nano Letters · doi:10.1021/nl052455y · Cited by 278
Self-citationCo‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates
Zhang, L., Radovic‐Moreno, A. F., Alexis, F., Gu, F. X., Basto, P. A., Bagalkot, V., Jon, S., Langer, R. S., & Farokhzad, O. C. (2007) · ChemMedChem · doi:10.1002/cmdc.200700121 · Cited by 257
Self-citationSapra, P., & Allen, T. M. (2002) · PubMed · Cited by 242
Controlling liposome blood clearance by surface-grafted polymers
Woodle, M. C. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00136-1 · Cited by 242
Targeted nanoparticle-based drug delivery and diagnosis
Emerich, D. F., & Thanos, C. G. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701231810 · Cited by 228
Tanaka, T., Shiramoto, S., Miyashita, M., Fujishima, Y., & Kaneo, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.050 · Cited by 206
Hybrid Virus−Polymer Materials. 1. Synthesis and Properties of PEG-Decorated Cowpea Mosaic Virus
Raja, K. S., Wang, Q., Gonzalez, M. J., Manchester, M., Johnson, J. E., & Finn, M. G. (2003) · Biomacromolecules · doi:10.1021/bm025740+ · Cited by 205
Polymersome Encapsulated Hemoglobin: A Novel Type of Oxygen Carrier
Arifin, D. R., & Palmer, A. F. (2005) · Biomacromolecules · doi:10.1021/bm0501454 · Cited by 192
Nanoparticle-Based Diagnosis and Therapy
Groneberg, D. A., Giersig, M., Welte, T., & Pison, U. (2006) · Current Drug Targets · doi:10.2174/138945006777435245 · Cited by 158
Dutta, T., Agashe, H. B., Garg, M., Balasubramanium, P., Kabra, M., & Jain, N. K. (2007) · Journal of drug targeting · doi:10.1080/10611860600965914 · Cited by 157
Improved Oral Delivery of Paclitaxel Following Administration in Nanoemulsion Formulations
Tiwari, S. B., & Amiji, M. M. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.440 · Cited by 139
Bissett, D., Cassidy, J., Bono, J. S. D., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601922 · Cited by 125
Wosikowski, K., Biedermann, E., Rattel, B., Breiter, N., Jank, P., Löser, R., Jansen, G., & Peters, G. J. (2003) · PubMed · Cited by 115
Wong, H. L., Rauth, A. M., Bendayan, R., & Wu, X. Y. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.10.022 · Cited by 109
Schnyder, A., Krähenbühl, S., Drewe, J., & Huwyler, J. (2005) · Journal of drug targeting · doi:10.1080/10611860500206674 · Cited by 104
PEGylated Peptide Dendrimeric Carriers for the Delivery of Antimalarial Drug Chloroquine Phosphate
Bhadra, D., Bhadra, S., & Jain, N. K. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-9396-9 · Cited by 102
Nanoparticle Albumin–Bound Paclitaxel for Metastatic Breast Cancer
Harries, M., Ellis, P., & Harper, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.002 · Cited by 100
Chavanpatil, M. D., Khdair, A., & Panyam, J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9203-2 · Cited by 98
Fonseca, M. J., Jagtenberg, J. C., Haisma, H. J., & Storm, G. (2003) · Pharmaceutical Research · doi:10.1023/a:1022608321861 · Cited by 45
XIE, Y., LU, W., & JIANG, X. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.06.001 · Cited by 43
Hoekstra, R., Dumez, H., Eskens, F. A. L. M., van der Gaast, A., Planting, A. S. T., de Heus, G., Sizer, K. C., Ravera, C., Vaidyanathan, S., Bucana, C. D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0720 · Cited by 39
In vitroandIn vivoAntitumor Activity of the Novel Derivatized Polyvinyl Alcohol-Based Polymer P10(4)
Raffaghello, L., Zuccari, G., Carosio, R., Orienti, I., & Montaldo, P. G. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2318 · Cited by 15
Cited by
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Self-citationStrategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Self-citation
Metadata
- Authors
- Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2007-10-24
- Volume
- 83
- Issue
- 5
- Pages
- 761-769
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2089155556
- Cited by
- 2,657
- References
- 47
- FWCI
- 22.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.